Connection

Oliver Cornely to Administration, Intravenous

Back to Details
This is a "connection" page, showing publications Oliver Cornely has written about Administration, Intravenous.
Oliver Cornely
Connection Strength
0.486
Administration, Intravenous
  1. Isavuconazole for treatment of rare invasive fungal diseases. Mycoses. 2018 Aug; 61(8):518-533.
    View in: PubMed
    Score: 0.136
  2. Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease. J Antimicrob Chemother. 2017 Dec 01; 72(12):3406-3413.
    View in: PubMed
    Score: 0.130
  3. Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia. J Antimicrob Chemother. 2017 08 01; 72(8):2359-2367.
    View in: PubMed
    Score: 0.127
  4. Isavuconazole for treatment of invasive fungal diseases caused by more than one fungal species. Mycoses. 2018 Jul; 61(7):485-497.
    View in: PubMed
    Score: 0.033
  5. Pharmacokinetic Modeling of Voriconazole To Develop an Alternative Dosing Regimen in Children. Antimicrob Agents Chemother. 2018 01; 62(1).
    View in: PubMed
    Score: 0.033
  6. Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis. Lancet Infect Dis. 2016 Jul; 16(7):828-837.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.